PSMA, What It Is and Why It Matters to Prostate Cancer Patients

Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education
PHEN
Discusses definitions and differences between PSA and PSMA

Michael J. Morris, MD
Medical Oncologist
MSKCC, Sydney Kimmel Center for Prostate Cancer
Discusses the successful VISION clinical trial.

Michael Groaning, PhD
Global Medical Affairs Lead
Amgen
Discusses Amgen’s AMG160 clinical trial.